CLN3 and neuronal ceroid lipofuscinosis: Similar strategies have also been tested in infantile NCL by crossing to Rag1-deficient mice (34), or immunomodulatory drug treatment (11), both positively influencing disease progression in both Ppt1 and Cln3-deficient mice.